Walleye Trading’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$532K Buy
1,821
+393
+28% +$75.2K ﹤0.01% 2656
2026
Q1
$237K Sell
1,428
-1,069
-43% -$175K ﹤0.01% 3019
2025
Q4
$398K Buy
+2,497
New +$343K ﹤0.01% 2974
2022
Q1
Sell
-4
Closed -$3K 5624
2021
Q4
$3K Buy
+4
New +$3.83K ﹤0.01% 5237
2019
Q3
Sell
-20
Closed -$20K 4220
2019
Q2
$20K Buy
+20
New +$19.4K ﹤0.01% 3744
2019
Q1
Sell
-40
Closed -$41.6K 4492
2018
Q4
$26K Sell
40
-55
-58% -$57.7K ﹤0.01% 4296
2018
Q3
$176K Buy
+95
New +$187K ﹤0.01% 3852
2017
Q3
Sell
-78
Closed -$108K 4380
2017
Q2
$99K Buy
78
+61
+359% +$61.5K ﹤0.01% 3552
2017
Q1
$16K Buy
+17
New +$15.1K ﹤0.01% 4208
2016
Q4
Sell
-68
Closed -$51.1K 4948
2016
Q3
$66K Buy
+68
New +$56.1K ﹤0.01% 3581

Other funds holding LABU

Walleye Trading's LABU Position: Q2 2026 in Review

Walleye Trading increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 28% in Q2 2026, buying an estimated $75.2K and bringing the position to 1,821 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Walleye Trading first reported a position in LABU in Q3 2016 and has held it in 10 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Walleye Trading held 1,821 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $532K as of Q2 2026.
  • Walleye Trading bought 393 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $75.2K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2656 holding.
  • Walleye Trading first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2016 and has held it in 10 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.